THURSDAY February 7th FRIDAY February 8th SATURDAY February 9th SUNDAY February 10th POSTERS

SATURDAY, FEBRUARY 9, 2002 select a session: THE REVIVAL OF THERAPEUTIC ANTIBODIES NEORAL C2 MONITORING: EVOLUTION IN EXCELLENCE CELL THERAPIES TRANSPLANTATION RESEARCH IN PROGRESS

8:30 - 12:00 Hall A THE REVIVAL OF THERAPEUTIC ANTIBODIES Chairpersons: Herman Waldmann, Oxford, UK Lucienne Chatenoud, Paris, France 8:30 - 9:00 REPROGRAMMING THE IMMUNE SYSTEM USING ANTIBODIES Herman Waldmann Oxford, UK 9:00 - 9:30 ANTI TNF ALPHA ANTIBODY THERAPY IN ARTHRITIS - RHEUMATOID FUTURE OPPORTUNITIES Marc Feldmann Ravinder N. Maini Brian M. J. Foxwell Fionula M. Brennan London, UK 9:30 - 11:00 COFFEE BREAK AND GUIDED POSTER SESSION 11:00 - 11:30 THE USE OF CAMPATH-1H INDUCTION AND RAPAMYCIN MONOTHERAPY IN RENAL TRANSPLANT RECIPIENTS Stuart J. Knechtle Nancy R. Krieger John D. Pirsch Bryan N. Becker L. Thomas Chin Yolanda T. Becker Jon S. Odorico Anthony M. D'Alessandro Munci Kalayoglu Hans W. Sollinger Madison, USA 11:30 - 12:00 THE FUTURE OF ANTI-CD3 ANTIBODIES Lucienne Chatenoud Paris, France 12:00 - 13:00 Hall A NEORAL ® C2 MONITORING: EVOLUTION IN EXCELLENCE - SESSION SPONSORED BY NOVARTIS PHARMA AG Chairpersons: Björn Nashan Hannover, Germany 12:00 NEORAL® AS THE FOUNDATION OF IMMUNOSUPPRESSION IN TRANSPLANTATION Björn Nashan, Hannover, Germany 12:15 MANAGEMENT OF THE DE NOVO TRANSPLANT RECIPIENT USING NEORAL® C2 MONITORING Gary A Levy, Toronto, Canada 12:30 CLINICAL BENEFITS OF NEORAL® C2 MONITORING IN THE MAINTENANCE TRANSPLANT RECIPIENT Franco Citterio, Rome, Italy 12:45 OUTCOMES OF NEORAL® MONITORING IN CLINICAL PRACTICE Edward Cole, Toronto, Canada 13:00 - 14:30 LUNCH BREAK 14:30 - 16:30 Hall A CELL THERAPIES Chairpersons: Kathryn J Wood, Oxford, UK Jean-Paul Soulillou, Nantes, France 14:30 - 15:00 CELL-BASED STRATEGIES TO INDUCE TRANSPLANTATION TOLERANCE Kathryn Wood Oxford, UK 15:00 - 15:30 NOVEL IMMUNOSUPPRESSION PROTOCOLS IN ISLET TRANSPLANTATION Bernhard Hering Minneapolis, USA 15:30 - 16:00 TCR ß CHAINS TRANSCRIPT REGULATION IN REJECTION AND TOLERANCE Jean-Paul Soulillou Nantes, France 16:00 - 16:30 COFFEE BREAK 16:30 - 18:45 Hall A TRANSPLANTATION RESEARCH IN PROGRESS: HIGHLIGHTS OF PROJECTS SUPPORTED BY THE ROCHE ORGAN TRANSPLANTION RESEARCH FOUNDATION (ROTRF) Chairpersons: Philip F. Halloran, Edmonton, Canada Pekka Häyry, Helsinki, Finland 16:30 - 16:40 INTRODUCTION Philip F. Halloran Edmonton, Canada 16:40 - 16:55 PHENOTYPE AND FUNCTION OF IMMUNOREGULATORY T CELLS RESPONSIBLE FOR TOLERANCE TO ALLOANTIGENS IN VIVO Kathryn Wood Oxford, UK 16:55 - 17:10 ANTI-REJECTION THERAPY INHIBITING FUCOSE-DEPENDENTLEUKOCYTE TRAFFIC Risto Renkonen Helsinki, Finland 17:10 - 17:25 THE ROLE OF TRANCE/TRANCE-RECEPTOR INTERACTION DURING ALLOGENIC IMMUNE RESPONSES IN VIVO Regis Josien Nantes, France 17:25 - 17:40 TRANSCRIPTION FACTOR STAT5A/B: A NOVEL TARGET FOR REGULATING T CELL ACTIVITY AND ALLOGRAFT REJECTION Robert Kirken Houston, USA 17:40 - 17:55 HEME OXYGENASE-1: AN ANTI- INFLAMMATORY MOLECULE THAT PROMOTES ORGAN GRAFT SURVIVAL Miguel Soares Boston, USA 17:55 - 18:10 USE OF PROTEOSOME INHIBITORS TO CONTROL REJECTION AND TO INDUCE LONG- TERM TOLERANCE OF ORGAN GRAFTS Jianping Wu Montreal, Canada 18:10 - 18:25 STUDY OF THE ROLE OF GAMMA-DELTA T LYMPHOCYTES IN THE IMMUNE RESPONSE DIRECTED AGAINST HUMAN CYTOMEGALOVIRUS Julie Dechanet Bordeaux, France 18:25 - 18:40 REDUCTION IN DIABETIC HYPERGLYCEMIA BY GLUCOSE-REGULATED INSULIN RELEASE FROM TRANSDUCED HEPATOCYTES` Tausif Alam Madison, USA 18:40 - 18:45 CLOSING REMARKS Pekka Häyry Helsinki, Finland THURSDAY February 7th FRIDAY February 8th SATURDAY February 9th SUNDAY February 10th POSTERS